Cargando…
Editorial: Risks and Benefits of Adjuvants to Cancer Therapies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149592/ https://www.ncbi.nlm.nih.gov/pubmed/35651808 http://dx.doi.org/10.3389/fonc.2022.913626 |
| _version_ | 1784717234015305728 |
|---|---|
| author | Dong, Peixin Gewirtz, David A. |
| author_facet | Dong, Peixin Gewirtz, David A. |
| author_sort | Dong, Peixin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9149592 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91495922022-05-31 Editorial: Risks and Benefits of Adjuvants to Cancer Therapies Dong, Peixin Gewirtz, David A. Front Oncol Oncology Frontiers Media S.A. 2022-05-16 /pmc/articles/PMC9149592/ /pubmed/35651808 http://dx.doi.org/10.3389/fonc.2022.913626 Text en Copyright © 2022 Dong and Gewirtz https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Dong, Peixin Gewirtz, David A. Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title | Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title_full | Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title_fullStr | Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title_full_unstemmed | Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title_short | Editorial: Risks and Benefits of Adjuvants to Cancer Therapies |
| title_sort | editorial: risks and benefits of adjuvants to cancer therapies |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149592/ https://www.ncbi.nlm.nih.gov/pubmed/35651808 http://dx.doi.org/10.3389/fonc.2022.913626 |
| work_keys_str_mv | AT dongpeixin editorialrisksandbenefitsofadjuvantstocancertherapies AT gewirtzdavida editorialrisksandbenefitsofadjuvantstocancertherapies |